HBeAg seroconversion is associated with a more effective PD-L1 blockade during chronic hepatitis B infection

BACKGROUND & AIMS: Current therapies for chronic hepatitis B virus (HBV) infection control viral replication but do not eliminate the risk of progression to hepatocellular carcinoma. HBV-specific CD8 T cells are necessary for viral control, but they are rare and exhausted during chronic infectio...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrando-Martinez, Sara, Huang, Kelly, Bennett, Angie Snell, Sterba, Patricia, Yu, Li, Suzich, JoAnn A., Janssen, Harry L.A., Robbins, Scott H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001560/
https://www.ncbi.nlm.nih.gov/pubmed/32039367
http://dx.doi.org/10.1016/j.jhepr.2019.06.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001560/
https://www.ncbi.nlm.nih.gov/pubmed/32039367
http://dx.doi.org/10.1016/j.jhepr.2019.06.001

Ejemplares similares